This one hour webinar will help you understand the steps that must be taken when transitioning assays between different technologies. It will make sure that you have a full understanding of the legacy technology and the current technology and develop a transition plan to make sure results could be easily compared between the two technologies.
The webinar will include the following critical information you will need:
Laboratories need a transition of technologies all the time. From new ways to perform assays to outdated technology, to new equipment pushes to the various needs of end users, assays need to switch between technologies on a regular basis. One must be able to easily and robustly transition assays from one technology to another. With this webinar, you will be able to fully understand how your assay is currently running and make a note of what the new technology should be able to work for you. Then you will learn how to slowly get the new technology up and running, validating the quality system, equipment and the assay itself, what you need to understand in the process of transitioning old samples onto the new system and deal with any potential issues. Finally, you will also get trained to develop a validation plan that will allow you to embrace the new technology fearlessly.
Todd Graham is a clinical laboratory scientist for a large hospital system in the New York Tri-State Area, as well as a scientific consultant for Fortune 500 biotechnology firms, healthcare systems throughout the world, and R1 Research Level Universities. During his time as a clinical laboratory scientist in his current role, Todd has improved sample workflow and improved laboratory quality and sample turnaround time while expanding laboratory services to vulnerable health populations in the New York area. He has also provided outreach to the local community by serving as a mentor to students training in clinical laboratory science, as well as the scientific community by serving as a technical resource for his peers in the laboratory.
Through his work as a consultant, he has worked to improve the spread of key technical information in a variety of mediums. He has written several market research reports used by Fortune 500 biotechnology firms in strategic planning and led webinars on key quality issues that impact the biotechnology community. He has served R1 Research Level Universities by advising them on strategic technology transfer opportunities and has been called upon as a key knowledge leader internationally for the biotechnology industry.
Todd graduated in 2006 with an M.A. in Biology at Queens College (City University of New York) after conducting published research in Molecular Evolution in the laboratory of Dr. Stephane Boissinot. He graduated as a Dean’s List student and James Dickson Carr Scholar from Rutgers University in 2001 with a BS in Biotechnology, where he continues to mentor Biotechnology students. He is a member of the Society for Laboratory Automation and Screening. He is also licensed as a Clinical Laboratory Technologist in New York State and is certified in Molecular Diagnostics by the American Society for Clinical Pathology.